IL-6 increases B-cell IgG production in a feed-forward proinflammatory mechanism to skew hematopoiesis and elevate myeloid production.

Src homology 2 domain-containing inositol 5-phosphatase (SHIP(-/-)) animals display an age-related increase in interleukin-6 (IL-6), a decrease in B lymphopoiesis, and an elevation in myelopoiesis. We investigated the origin of the IL-6 production and show that it is largely produced by peritoneal and splenic macrophages. IL-6 production by these macrophages is not a direct result of the loss of SHIP: IL-6 production is not spontaneous, is absent from bone marrow-derived macrophages, declines with prolonged culture of macrophages, and requires a stimulus present in vivo. The IL-6-rich peritoneal cavity of SHIP(-/-) mice shows more than 700-fold more immunoglobulin G (IgG) than wild-type, approximately 20% of which is aggregated or in an immune complex and contains B220(+) cells that secrete IgG. The SHIP-deficient peritoneal macrophages show evidence of IgG receptor stimulation. Animals lacking both the signal-transducing gamma-chain of IgG receptors and SHIP or Ig and SHIP produce less IL-6. The data indicate a feed-forward process in which peripheral macrophages, responding through IgG receptors to secreted IgG, produce IL-6, to support further B-cell production of IgG. Because of the proinflammatory phenotype of SHIP(-/-) animals, these findings emphasize the importance of IL-6-neutralizing strategies in autoimmune and proinflammatory diseases.

[1]  P. Sfikakis,et al.  The pathophysiologic role of monocytes and macrophages in systemic lupus erythematosus: a reappraisal. , 2010, Seminars in arthritis and rheumatism.

[2]  R. Flavell,et al.  SHIP Represses the Generation of IL-3-Induced M2 Macrophages by Inhibiting IL-4 Production from Basophils1 , 2009, The Journal of Immunology.

[3]  K. Coggeshall,et al.  Interleukin-6 aborts lymphopoiesis and elevates production of myeloid cells in systemic lupus erythematosus-prone B6.Sle1.Yaa animals. , 2009, Blood.

[4]  M. Glogauer,et al.  Adaptor Protein SLAT Modulates Fcγ Receptor-mediated Phagocytosis in Murine Macrophages* , 2009, Journal of Biological Chemistry.

[5]  H. Anders,et al.  The role of innate immunity in autoimmune tissue injury , 2008, Current opinion in rheumatology.

[6]  Mikkel Ostergaard,et al.  Biomarkers of inflammation in patients with unclassified polyarthritis and early rheumatoid arthritis. Relationship to disease activity and radiographic outcome. , 2008, The Journal of rheumatology.

[7]  G. Schett Review: Immune cells and mediators of inflammatory arthritis , 2008, Autoimmunity.

[8]  R. Cornall,et al.  MyD88‐dependent autoimmune disease in Lyn‐deficient mice , 2007, European journal of immunology.

[9]  C. Suh,et al.  Cytokine IL-6 and IL-10 as Biomarkers in Systemic Lupus Erythematosus , 2007, Journal of Clinical Immunology.

[10]  D. Fruman,et al.  Role of phosphoinositide 3-kinase signaling in autoimmunity , 2007, Autoimmunity.

[11]  Xiao-yu R. Song,et al.  Anti‐interleukin‐6 monoclonal antibody inhibits autoimmune responses in a murine model of systemic lupus erythematosus , 2006, Immunology.

[12]  T. Mayadas,et al.  Vav Proteins in Neutrophils Are Required for FcγR-Mediated Signaling to Rac GTPases and Nicotinamide Adenine Dinucleotide Phosphate Oxidase Component p40(phox)1 , 2006, The Journal of Immunology.

[13]  M. Caligiuri,et al.  FcgammaR-induced production of superoxide and inflammatory cytokines is differentially regulated by SHIP through its influence on PI3K and/or Ras/Erk pathways. , 2006, Blood.

[14]  G. Firestein Inhibiting inflammation in rheumatoid arthritis. , 2006, The New England journal of medicine.

[15]  A. Mui,et al.  SHIP represses the generation of alternatively activated macrophages. , 2005, Immunity.

[16]  Emilio Hirsch,et al.  Blockade of PI3Kγ suppresses joint inflammation and damage in mouse models of rheumatoid arthritis , 2005, Nature Medicine.

[17]  D. F. Barber,et al.  PI3Kγ inhibition blocks glomerulonephritis and extends lifespan in a mouse model of systemic lupus , 2005, Nature Medicine.

[18]  Y. Baba,et al.  IL-6 blocks a discrete early step in lymphopoiesis. , 2005, Blood.

[19]  V. Vedham,et al.  Vav Activation and Function as a Rac Guanine Nucleotide Exchange Factor in Macrophage Colony-Stimulating Factor-Induced Macrophage Chemotaxis , 2005, Molecular and Cellular Biology.

[20]  Michael C. Ostrowski,et al.  The Serine/Threonine Kinase Akt Promotes Fcγ Receptor-mediated Phagocytosis in Murine Macrophages through the Activation of p70S6 Kinase* , 2004, Journal of Biological Chemistry.

[21]  C. Quilici,et al.  Perturbed myelo/erythropoiesis in Lyn-deficient mice is similar to that in mice lacking the inhibitory phosphatases SHP-1 and SHIP-1. , 2004, Blood.

[22]  A. Roberts,et al.  Critical role for granulocyte colony-stimulating factor in inflammatory arthritis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[23]  G. Krystal,et al.  LPS-induced upregulation of SHIP is essential for endotoxin tolerance. , 2004, Immunity.

[24]  D. Fruman Phosphoinositide 3-kinase and its targets in B-cell and T-cell signaling. , 2004, Current opinion in immunology.

[25]  P. Lipsky,et al.  Rationale for interleukin-6 blockade in systemic lupus erythematosus , 2004, Lupus.

[26]  N. Van Rooijen,et al.  Subpopulations of Mouse Blood Monocytes Differ in Maturation Stage and Inflammatory Response1 , 2004, The Journal of Immunology.

[27]  K. Coggeshall,et al.  Src Homology 2–containing 5-Inositol Phosphatase (SHIP) Suppresses an Early Stage of Lymphoid Cell Development through Elevated Interleukin-6 Production by Myeloid Cells in Bone Marrow , 2004, The Journal of experimental medicine.

[28]  S. Koyasu The role of PI3K in immune cells , 2003, Nature Immunology.

[29]  B. Nilsson,et al.  Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an FcγRII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE , 2003, Annals of the rheumatic diseases.

[30]  K. Coggeshall,et al.  The Src homology 2 domain-containing inositol 5-phosphatase negatively regulates Fcgamma receptor-mediated phagocytosis through immunoreceptor tyrosine-based activation motif-bearing phagocytic receptors. , 2002, Blood.

[31]  Y. Saeki,et al.  A Point Mutation of Tyr-759 in Interleukin 6 Family Cytokine Receptor Subunit gp130 Causes Autoimmune Arthritis , 2002, The Journal of experimental medicine.

[32]  P. Wiernik,et al.  Systemic lupus erythematosus and B-cell hematologic neoplasm , 2001, Lupus.

[33]  A. Jacob,et al.  Signal Transduction by Human-Restricted FcγRIIa Involves Three Distinct Cytoplasmic Kinase Families Leading to Phagocytosis1 , 2001, The Journal of Immunology.

[34]  M. Hughes,et al.  Role of Src homology 2-containing-inositol 5'-phosphatase (SHIP) in mast cells and macrophages. , 2001, Biochemical Society transactions.

[35]  J. Freed,et al.  Differential Regulation of B Cell Development, Activation, and Death by the Src Homology 2 Domain–Containing 5′ Inositol Phosphatase (Ship) , 2000, The Journal of experimental medicine.

[36]  G. Krystal,et al.  A Dual Role for Src Homology 2 Domain–Containing Inositol-5-Phosphatase (Ship) in Immunity , 2000, The Journal of experimental medicine.

[37]  H. Broxmeyer,et al.  Altered responsiveness to chemokines due to targeted disruption of SHIP. , 1999, The Journal of clinical investigation.

[38]  D. Cooney,et al.  The SH2-containing 5'-inositol phosphatase (SHIP) is tyrosine phosphorylated after Fc gamma receptor clustering in monocytes. , 1999, Journal of immunology.

[39]  T. Kelley,et al.  FcγRIIb Modulation of Surface Immunoglobulin-induced Akt Activation in Murine B Cells* , 1999, The Journal of Biological Chemistry.

[40]  J. Hamilton,et al.  Protection from collagen-induced arthritis in granulocyte-macrophage colony-stimulating factor-deficient mice. , 1998, Journal of immunology.

[41]  T. Yamazaki,et al.  Resistance of Fc receptor- deficient mice to fatal glomerulonephritis. , 1998, The Journal of clinical investigation.

[42]  M. Huber,et al.  The src homology 2-containing inositol phosphatase (SHIP) is the gatekeeper of mast cell degranulation. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[43]  G. Krystal,et al.  Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. , 1998, Genes & development.

[44]  Y. Ohsugi,et al.  IL‐6 receptor blockage inhibits the onset of autoimmune kidney disease in NZB/W F1 mice , 1998, Clinical and experimental immunology.

[45]  E. Chan,et al.  Fc gamma receptor cross-linking activates p42, p38, and JNK/SAPK mitogen-activated protein kinases in murine macrophages: role for p42MAPK in Fc gamma receptor-stimulated TNF-alpha synthesis. , 1997, Journal of immunology.

[46]  T. Tatsumi,et al.  Interleukin-6 overexpression cannot generate serious disorders in severe combined immunodeficiency mice. , 1997, Clinical immunology and immunopathology.

[47]  P. Li,et al.  ANTI‐DNA AUTOANTIBODIES STIMULATE THE RELEASE OF INTERLEUKIN‐1 AND INTERLEUKIN‐6 FROM ENDOTHELIAL CELLS , 1996, The Journal of pathology.

[48]  S. Stacker,et al.  Multiple defects in the immune system of Lyn-deficient mice, culminating in autoimmune disease , 1995, Cell.

[49]  W. de Souza,et al.  Subpopulations of mouse resident peritoneal macrophages fractionated on Percoll gradients show differences in cell size, lectin binding and antigen expression suggestive of different stages of maturation. , 1995, Tissue & cell.

[50]  J. M. Osborne,et al.  Clustering of the platelet Fc gamma receptor induces noncovalent association with the tyrosine kinase p72syk. , 1994, The Journal of biological chemistry.

[51]  D. Wofsy,et al.  Interleukin 6 promotes murine lupus in NZB/NZW F1 mice. , 1994, The Journal of clinical investigation.

[52]  P. Hawkins,et al.  A novel phosphoinositide 3 kinase activity in myeloid-derived cells is activated by G protein βγ subunits , 1994, Cell.

[53]  R. Zinkernagel,et al.  Impaired immune and acute-phase responses in interleukin-6-deficient mice , 1994, Nature.

[54]  J. Ravetch,et al.  FcR γ chain deletion results in pleiotrophic effector cell defects , 1994, Cell.

[55]  H. Nagafuchi,et al.  Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus. , 1993, Journal of immunology.

[56]  A. Duits,et al.  Isotype‐specific cross‐linking of select human FcγR isoforms triggers release of IL‐6 , 1993 .

[57]  M. Alarcón‐Riquelme,et al.  Macrophage depletion decreases IgG anti‐DNA in cultures from (NZB · NZW)F1 spleen cells by eliminating the main source of IL‐6 , 1993, Clinical and experimental immunology.

[58]  H. Metzger,et al.  Transmembrane signaling: the joy of aggregation. , 1992, Journal of immunology.

[59]  Klaus Rajewsky,et al.  A B cell-deficient mouse by targeted disruption of the membrane exon of the immunoglobulin μ chain gene , 1991, Nature.

[60]  J. Miyazaki,et al.  IgG1 plasmacytosis in interleukin 6 transgenic mice. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[61]  H. Asaoku,et al.  Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas , 1988, Nature.

[62]  P. Sehgal,et al.  Monocyte-derived human B-cell growth factor identified as interferon-beta 2 (BSF-2, IL-6). , 1988, Science.

[63]  T. Kishimoto,et al.  Isolation and characterization of B cell differentiation factor (BCDF) secreted from a human B lymphoblastoid cell line. , 1984, Journal of immunology.

[64]  H. Wagner Endogenous TLR ligands and autoimmunity. , 2006, Advances in immunology.

[65]  U. Knaus,et al.  New players in TLR-mediated innate immunity , 2006 .

[66]  T. Kishimoto Interleukin-6: from basic science to medicine--40 years in immunology. , 2005, Annual review of immunology.

[67]  M. Fritzler,et al.  Loss of a single allele of SHIP exacerbates the immunopathology of Pten heterozygous mice , 2003, Genes and Immunity.

[68]  M. Huber,et al.  The role of SHIP in cytokine-induced signaling. , 2003, Reviews of physiology, biochemistry and pharmacology.

[69]  G. Underhill,et al.  Longevity Cells in the Maintenance of Plasma Cell The Role of Bone Marrow-Derived Stromal , 2002 .

[70]  Matthew J. Silva,et al.  SHIP-deficient mice are severely osteoporotic due to increased numbers of hyper-resorptive osteoclasts , 2002, Nature Medicine.

[71]  T. Kelley,et al.  FcgammaRIIb modulation of surface immunoglobulin-induced Akt activation in murine B cells. , 1999, The Journal of biological chemistry.

[72]  P. Hawkins,et al.  A novel phosphoinositide 3 kinase activity in myeloid-derived cells is activated by G protein beta gamma subunits. , 1994, Cell.

[73]  A. Duits,et al.  Isotype-specific cross-linking of select human Fc gamma R isoforms triggers release of IL-6. , 1993, Clinical and experimental immunology.